During the past decade, BDD Pharma Ltd conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "BDD Pharma Ltd" are "Disintegration" (1 trials), "Healthy" (1 trials) and "Healthy Volunteers" (1 trials). Many other conditions were trialed in "BDD Pharma Ltd" in a lesser frequency.

Most popular intervention types in "BDD Pharma Ltd" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "4Mq 99mTc-DTPA" (1 trials), "Brilacidin" (1 trials), "EDP1815 capsule A" (1 trials), "EDP1815 capsule B" (1 trials) and "EDP1815 tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "BDD Pharma Ltd" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "BDD Pharma Ltd". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in BDD Pharma Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in BDD Pharma Ltd, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".